Royalty Pharma Plc (RPRX) Stock Institutional Owners
Royalty Pharma Plc (RPRX) is held by 3 institutional investors with a total value of $108.07M. This comprehensive analysis highlights the top institutional holders led by Dorsey Asset Management, Torray Fund, Sequoia Financial Advisors, and others, who collectively account for nearly 100% of the total institutional ownership.Dorsey Asset Management remains the largest institutional holder with a position worth $82.92M. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.
Explore more:
- Royalty Pharma Plc (RPRX) stock institutional trading activity
- Royalty Pharma Plc (RPRX) stock insider trading activity
- Stock rankings
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance |
|---|---|---|---|---|
| Dorsey Asset Management | Pat Dorsey | 7.45% | 2,350,449 | $82,923,841 |
| Torray Fund | Robert Torray | 3.36% | 702,883 | $24,797,712 |
| Sequoia Financial Advisors | 0.00% | 9,830 | $346,815 |
Frequently asked questions about RPRX
Who owns the most RPRX stock?
The largest holders of RPRX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for Royalty Pharma Plc (RPRX).
Is RPRX widely held by superinvestors?
Many widely followed stocks like RPRX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly RPRX is represented among the institutional managers we track.